Captozyme
Gainesville, US · Delaware corporation
Biotech
Founders & leadership
AB
AARON B. COWLEYNamed on SEC filing
QL
QING-SHAN LINamed on SEC filing
HC
HELENA COWLEYNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.4M disclosed across 1 round · 2016
▶$3.4MraisedSep 2016 · 1 investors · BiotechnologyRule 506(b)
▶$3.4MraisedSep 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- AARON B. COWLEYExecutive Officer, Director
- QING-SHAN LIExecutive Officer, Director
- HELENA COWLEYExecutive Officer, Director
- Offering amount
- $3.4M
- Amount sold
- $3.4M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Captozyme raised?
- Captozyme has disclosed $3.4M raised across 1 round.
- Where is Captozyme headquartered?
- Captozyme is headquartered in Gainesville, US.